Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.
Morrow Sodali is serving as the information agent for this transaction.
Download the pdf to see the Wall Street Journal ad.
Related News
How to Prep a CEO For the Scrutiny of Life Post-IPO: ECM Watch
25 August 2025
Sodali & Co Appoints Emily Wei and Hasib Nasirullah as Co-Leads of Global Sustainability Practice
19 August 2025
Sodali & Co Strengthens U.S. Corporate Governance Advisory with Appointment of Matthew Vahidi as Managing Director
13 August 2025
Entering a new phase of shareholder activism
04 August 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right